PQ 418
418. Deputy Pádraig Mac Lochlainn asked the Minister for Health if she will review the current reimbursement status of a medication (details supplied) under the drugs payment scheme and general medical services scheme; if her attention has been drawn to the fact that women who develop medically induced menopause as a result of cancer treatment, and who cannot use HRT due to hormone-sensitive cancers, are required to pay for this medication while women accessing HRT for natural menopause can do so free of charge under the HRT scheme; and if she will address this apparent inequity in access to menopause symptom management for cancer patients. [69450/26]
Introduced
1 October 2026
Last action
1 October 2026 · Medicinal Products
Status
written
Sponsors
Pádraig Mac Lochlainn
Subjects
Discovery layer
Source updated
1 October 2026
Summary
418. Deputy Pádraig Mac Lochlainn asked the Minister for Health if she will review the current reimbursement status of a medication (details supplied) under the drugs payment scheme and general medical services scheme; if her attention has been drawn to the fact that women who develop medically induced menopause as a result of cancer treatment, and who cannot use HRT due to hormone-sensitive cancers, are required to pay for this medication while women accessing HRT for natural menopause can do so free of charge under the HRT scheme; and if she will address this apparent inequity in access to menopause symptom management for cancer patients. [69450/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
1 October 2026
Medicinal Products
418. Deputy Pádraig Mac Lochlainn asked the Minister for Health if she will review the current reimbursement status of a medication (details supplied) under the drugs payment scheme and general medical services scheme; if her attention has been drawn to the fact that women who develop medically induced menopause as a result of cancer treatment, and who cannot use HRT due to hormone-sensitive cancers, are required to pay for this medication while women accessing HRT for natural menopause can do so free of charge under the HRT scheme; and if she will address this apparent inequity in access to menopause symptom management for cancer patients. [69450/26]
Source: written
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Medicinal Products
xml · EN · 1 October 2026
Sponsors
- Pádraig Mac Lochlainn · Asking member
- Health · Health · Addressed to
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-10-01/418/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-10-01/pq_418
- ireland · q-2026-10-01-pq_418 · source updated 1 October 2026